A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
M.D. Anderson Cancer Center
BicycleTx Limited
National University Hospital, Singapore
Bolt Biotherapeutics, Inc.
Mirror Biologics, Inc.
Mirror Biologics, Inc.
FeRx